Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Canadian Health Industry News.
Press releases published on June 26, 2025

Optimum Wound Care Center in Louisville Highlights Comprehensive Healing Process for Complex Wounds
Optimum Wound Care Promotes Recovery With Customized Treatment Plans for Chronic and Complex Wounds LOUISVILLE, KY, UNITED STATES, June 26, 2025 /EINPresswire.com/ -- Optimum Wound Care Center, a leading provider of outpatient wound treatment in …

Health Coalition responds to shocking attack, calls on Health Minister to desist & instead answer for non-action on private clinics with the gravitas the issue deserves
TORONTO, June 26, 2025 (GLOBE NEWSWIRE) -- Ontario Health Coalition executive director Natalie Mehra responded with the following letter to statements made on the Health Minister’s behalf by her spokespeople. The Coalition has been contacted by some media …

Ultrack Systems Inc. (OTC: MJLB) Launches “PUR Rx” — A Scalable Digital Healthcare Platform Through Joint Venture with Synergy Health Rx Corp.
CONCORD, Ontario, June 26, 2025 (GLOBE NEWSWIRE) -- Ultrack Systems Inc. (OTC: MJLB) is excited to announce the official launch of PUR Rx, a next-generation digital health platform formed through a 50/50 joint venture with Synergy Health Rx Corp. Designed …

COVID Institute Launches Nation’s First Epipharyngeal Abrasive Therapy Program for ‘Razor-Blade Throat’
COVID Institute now offering US clinical program for treating the sore-throat phenomenon, “razor-blade throat.” PLANO, TX, UNITED STATES, June 25, 2025 /EINPresswire.com/ -- COVID Institute today announced the United States’ first clinical program …

XORTX Announces USD $925,000 Private Placement
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, June 26, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late …

Medicenna Therapeutics Reports Fiscal Year 2025 Financial Results and Operational Highlights
Updated cash guidance provides runway into at least mid-2026 MDNA11 Phase 1/2 clinical trial on track for data readouts in second half of the year as a single agent and in combination with KEYTRUDA® at medical conferences and a planned KOL event MDNA11 …